MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.accpm.2024.101386

Медицинская библиотека · Anaesthesia, critical care & pain medicine · 2024

Intraoperative dexamethasone is associated with a lower risk of respiratory failure in thoracic surgery: Observational cohort study (SURTHODEX).

Braik Rayan, Germain Yohan, Flet Thomas, Chaba Anis, Guinot Piere-Grégoire, Garreau Leo, Bar Stephane, Diouf Momar, Abou-Arab Osama, Mahjoub Yazine, Berna Pascal, Dupont Hervé

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Postoperative complications, particularly respiratory complications, are of significant clinical concern in patients undergoing elective thoracic surgery. Dexamethasone (DXM), commonly administered to prevent postoperative nausea and vomiting (PONV), has potential anti-inflammatory effects that might be beneficial in reducing these complications. We aimed to investigate whether intraoperative DXM administration could mitigate the occurrence of respiratory complications following elective thoracic surgery.

METHODS

We conducted a single-center observational study, including patients who underwent elective thoracic surgery from 2012 to 2020. The primary outcome was the onset of acute respiratory failure within 7 days post-surgery. Secondary outcomes encompassed other postoperative complications, duration of hospital stay, and mortality within 30 days post-surgery. An overlap propensity score analysis was employed to estimate the treatment effect.

RESULTS

We included 1,247 adult patients, 897 who received dexamethasone (DXM) and 350 who served as controls. Intraoperative dexamethasone administration was associated with a significant reduction in respiratory complications with an adjusted relative risk (RR) of 0.65 (95% CI: 0.43-0.97). There was also a significant decline in composite infectious criteria with an adjusted RR of 0.76 (95% CI: 0.63-0.93). Cardiac complications were also assessed as a composite criterion, and a significant reduction was observed (adjusted RR, 0.68; 95% CI, 0.51-0.9). However, there were no association with mechanical complications, mortality within 30 days (adjusted RR of 0.43, 95% CI: 0.17-1.09) or in the length of hospital stay (adjusted RR of 0.85, 95% CI: 0.71-1.02).

CONCLUSIONS

Dexamethasone administration was associated with a reduction in postoperative respiratory complications. Further prospective studies are needed to confirm these findings.

Для цитирования: Braik Rayan, Germain Yohan, Flet Thomas, Chaba Anis, Guinot Piere-Grégoire, Garreau Leo, Bar Stephane, Diouf Momar, Abou-Arab Osama, Mahjoub Yazine, Berna Pascal, Dupont Hervé. Intraoperative dexamethasone is associated with a lower risk of respiratory failure in thoracic surgery: Observational cohort study (SURTHODEX).. Anaesthesia, critical care & pain medicine. 2024. DOI: 10.1016/j.accpm.2024.101386.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.